-
FEASIBILITY ASSESSMENT OF INDIRECT TREATMENT COMPARISON BETWEEN OFF-LABEL RITUXIMAB AND NOVEL TREATMENTS IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA
Mar 18, 2026, 21:38 PM -
ESTIMATING PRODUCTIVITY LOSS FROM A SOCIETAL PERSPECTIVE: A PRACTICAL FRAMEWORK USING U.S. PUBLIC-USE DATA
Mar 18, 2026, 21:38 PM -
EARLY PERSPECTIVES ON HEALTH TECHNOLOGY ASSESSMENT IN THE KINGDOM OF SAUDI ARABIA: EXPLORATORY SURVEY INTO MARKET ACCESS IMPLICATIONS
Mar 18, 2026, 21:38 PM -
A STRUCTURED FRAMEWORK FOR SAMPLING STRATEGY DESIGN IN LARGE-SCALE REAL-WORLD CHART REVIEW STUDIES
Mar 18, 2026, 21:38 PM -
EXPLORING BURDEN IN RARE DISEASES: EXAMINING NEUROPSYCHOLOGICAL SYMPTOMS, FLARES, AND SLEEP QUALITY
Mar 18, 2026, 21:38 PM -
CLINICAL UNMET NEEDS AND NON-INVASIVE TREATMENT PREFERENCES IN HISL MANAGEMENT: A MIXED-METHODS STUDY IN CHINA
Mar 18, 2026, 21:38 PM -
ENHANCING ONCOLOGY REAL WORLD DATA QUALITY THROUGH CLINICALLY RELEVANT EDIT CHECKS IN A LARGE US COMMUNITY ONCOLOGY DATABASE
Mar 18, 2026, 21:38 PM -
EFFECTIVE COVERAGE OF STOMACH CANCER PREVENTION IN CHILE 2009-2024
Mar 18, 2026, 21:38 PM -
AI ADOPTION AND SENTIMENT AMONG CHINESE PHYSICIANS: BENCHMARKING THE “DIGITAL CONFIDENCE GAP” IN 2025
Mar 18, 2026, 21:38 PM -
EFFICACY OF SACITUZUMAB GOVITECAN AMONG METASTATIC TRIPLE-NEGATIVE BREAST CANCER PATIENTS IN REAL-WORLD SETTINGS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
NURSE STAFFING RATIOS AND PATIENT OUTCOMES IN PENNSYLVANIA: POLICY IMPLICATIONS AND HOSPITAL COSTS
Mar 18, 2026, 21:38 PM -
EFFECTIVENESS AND SAFETY OF GLP-1 RECEPTOR AGONISTS IN PATIENTS WITH WEIGHT RECURRENCE AFTER BARIATRIC SURGERY: A REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERNS AND HEALTHCARE COSTS IN PATIENTS WITH SMALL-CELL LUNG CANCER IN SOUTH KOREA: A NATIONWIDE REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
DELAYED EFFECT APPROACH TO RESOLVE THE CARER QALY TRAP
Mar 18, 2026, 21:38 PM -
REAL-WORLD ANALYSIS OF TREATMENT DELAYS IN METASTATIC NON-SMALL LUNG CANCER: DEMOGRAPHIC, CLINICAL AND PAYER DRIVERS
Mar 18, 2026, 21:38 PM -
ACCESS TO HEALTHCARE, UTILIZATION, AND EXPENDITURES AMONG ADULTS WITH DIABETES AND CARDIORENAL COMORBIDITIES
Mar 18, 2026, 21:38 PM -
INTERNATIONAL REFERENCE PRICING CAPS ARE HIGHLY DESIGN-SENSITIVE: CAP-SETTING COUNTRIES AND ACCESS SIGNALS FOR INCRETIN THERAPIES
Mar 18, 2026, 21:38 PM -
MIXED METHODS OF DATA CAPTURE ARE AN ADVANCEMENT IN DETERMINING REAL-WORLD DEMENTIA TREATMENT EFFECTIVENESS, RETROSPECTIVELY-THE BEACON STUDY
Mar 18, 2026, 21:38 PM -
RISK OF MAJOR ADVERSE KIDNEY EVENTS OF TRIGLYCERIDE-TARGETING LIPID-LOWERING THERAPIES VERSUS STATINS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Mar 18, 2026, 21:38 PM -
REAL-WORLD EVIDENCE IN CANADA: BASELINE ESTIMATES TO SUPPORT HEALTH TECHNOLOGY ASSESSMENT
Mar 18, 2026, 21:38 PM
